Foscarnet

Revision as of 00:38, 5 January 2014 by ShiSheng (talk | contribs)
Jump to navigation Jump to search
Foscarnet
FOSCAVIR® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Foscarnet is the conjugate base of the chemical compound with the formula HO2CPO3H2. This phosphonic acid derivative is (marketed by AstraZeneca as foscarnet sodium under the trade name Foscavir®) is an antiviralmedication used to treat herpes viruses, including cytomegalovirus (CMV) and herpes simplex viruses types 1 and 2 (HSV-1 and HSV-2). It is particularly used to treat CMV retinitis.

Category

Antiviral

US Brand Names

FOSCAVIR®

FDA Package Insert

Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages

Mechanism of Action

References